Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Interim Management Statement

16 Nov 2011 08:56

RNS Number : 1917S
Dunedin Enterprise Inv Trust PLC
16 November 2011
 

Dunedin Enterprise Investment Trust PLC (Company No SC52844) - Interim Management Statement

 

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") presents its Interim Management Statement for the period ended 30 September 2011. This is the Company's second interim management statement for the financial year to 31 December 2011, as required by the FSA Disclosure and Transparency Rule 4.3.

 

1. Unaudited net asset value per share

 

The unaudited net asset value per share at 30 September 2011 was 531.7p. This represents an increase of 1.3% from the level at 30 June 2011.

 

2. Share price and discount

 

The share price has decreased by 23.6% from 363p to 277.3p in the quarter to 30 September 2011. This compares to a decrease in the FTSE Small Cap Index of 14.9% over the same period.

 

Based upon the net asset value per share of 531.7p, the discount of the share price to the net asset value per share has increased from 30.9% to 47.9% in the quarter. This increase reflects a widening of discounts across the private equity investment trust sector. When cash is excluded from net assets then the discount increases to 55.2%.

 

3. Proposals from the Board

 

On 1 November 2011, the Board issued proposals for a change in the Company's investment policy, the introduction of a distribution policy and cancellation of the Company's share premium account. These proposals reflect the Board's concern regarding the discount at which the shares in the Company have been trading relative to their net asset value and the poor liquidity in the market for the shares. The Board undertook a strategic review of the Company and, as part of that review, consulted a number of the largest shareholders. The Board believe the proposals to be in the best interests of the Company and the shareholders as a whole and unanimously recommend that shareholders vote in favour of the Resolutions at the General Meeting to be held on Monday 28 November 2011 at 12 noon at the offices of Dunedin Capital Partners Limited at Dukes Court, 32 Dukes Court, St James's, London SW1Y 6DF.

 

4. Balance Sheet

The balance sheet as at 30 September 2011 is noted below:-

 

£'m

Investments:-

Dunedin managed

103.6

Third party managed

18.2

Listed private equity

16.1

Legacy technology funds

1.8

139.7

Cash and near cash

 21.2

Other assets and liabilities

(0.5)

Total net assets

160.4

Net asset value per share (p)

531.7

5. Net asset value movements

 

The portfolio of investments has been re-valued at 30 September 2011. The increase in net asset value in the quarter can be attributed to:-

·; an increase in the value of Dunedin managed investments of £2.1m. This was principally due to valuation uplifts at Capula, WFEL and Practice Plan where a combination of stronger maintainable earnings and reduced net debt have led to valuation increases,

·; within the European funds there was a net reduction in value of £0.4m principally due to exchange movements,

·; an increase in the value of the SWIP Private Equity Fund of Funds II PLC from €0.82 per share to €0.84 per share was offset by exchange movements leading to a reduction in value of £0.2m,

·; in the quarter the Trust recovered £1.3m of VAT and interest charged on management fees from HMRC, and

·; other movements of -£0.8m.

Included within the net assets value movements noted above are exchange movements totalling -£1.2m.

 

6. Banking Facilities

 

The Company entered into a one year £10m revolving credit facility on 1 September 2011 with Lloyds Bank.

 

7. Commitments

 

As at 30 September 2011 the Company has outstanding capital commitments to limited partnership funds of £63.2m, of which £20m is unlikely to be called down. The Trust has cash and near cash balances of £21.2m at 30 September 2011.

 

8. Financial Adviser and Corporate Broker

 

With effect from 1 November 2011, Canaccord Genuity Limited was appointed the Company's financial adviser and corporate broker.

 

9. Outlook

 

The market remains very competitive but the outlook for portfolio add-ons is encouraging.

 

 

For further information on Dunedin Enterprise please go to www.dunedin.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGIBDBSUBBGBL
Date   Source Headline
30th Nov 202212:10 pmRNSHolding(s) in Company
29th Nov 20225:25 pmRNSHolding(s) in Company
29th Nov 202210:42 amRNSHolding(s) in Company
28th Nov 20229:06 amRNSHolding(s) in Company
25th Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSResult of Tender Offer
16th Nov 202212:52 pmRNS3rd Quarter Results
16th Nov 202212:49 pmRNSResult of General Meeting
4th Nov 202210:00 amRNSHolding(s) in Company
4th Nov 20228:51 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSQ3 Preliminary NAV and Tender Offer Price
21st Oct 20227:00 amRNSInterim Dividend
21st Oct 20227:00 amRNSTender Offer
7th Oct 20227:00 amRNSPortfolio Update
16th Sep 20227:00 amRNSHalf-year Report
25th Aug 20229:15 amRNSPortfolio Update
1st Aug 20227:00 amRNSPreliminary unaudited net asset value at 30/6/22
11th May 20222:58 pmRNSResult of AGM
11th May 20221:26 pmRNS1st Quarter Results
3rd May 20227:00 amRNSPreliminary unaudited net asset value at 31/3/22
13th Apr 202210:47 amRNSDirector/PDMR Shareholding
21st Mar 202212:43 pmRNSPortfolio Update
18th Mar 20227:00 amRNSAnnual Financial Report
2nd Mar 202212:41 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSDividend Declaration
1st Feb 20227:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/21
16th Dec 20213:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSPortfolio Update
8th Dec 202110:05 amRNSListing Rule 9.6.14
1st Dec 202110:02 amRNSDirector/PDMR Shareholding
1st Dec 202110:01 amRNSDirector/PDMR Shareholding
26th Nov 202112:45 pmRNSDirector/PDMR Shareholding
26th Nov 202112:44 pmRNSDirector/PDMR Shareholding
26th Nov 202112:42 pmRNSDirector/PDMR Shareholding
24th Nov 20217:56 amRNSDirector/PDMR Shareholding
24th Nov 20217:54 amRNSDirector/PDMR Shareholding
24th Nov 20217:46 amRNSHolding(s) in Company
19th Nov 20218:18 amRNSHolding(s) in Company
19th Nov 20217:00 amRNS3rd Quarter Results
16th Nov 20217:00 amRNSResult of Tender Offer
10th Nov 202111:43 amRNSResult of General Meeting
1st Nov 20217:00 amRNSQ3 Preliminary NAV and Tender Offer Price
18th Oct 20219:20 amRNSTender Offer
13th Oct 202110:00 amRNSPortfolio Update
6th Oct 20217:00 amRNSDividend Declaration
21st Sep 202110:00 amRNSCapital Reorganisation
16th Sep 20217:00 amRNSHalf-year Report
2nd Aug 20217:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/21
30th Jul 202112:25 pmRNSCapital Reorganisation
7th Jul 20211:13 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.